Association of Matrix Metalloproteinase-2 Genotypes With Prostate Cancer Risk

Po-Han Li1,2, Cheng-Hsi Liao1,3,4, Wen-Chin Huang1,5

  • 1Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.

Anticancer Research
|December 30, 2022
PubMed
Summary

This study found no significant association between specific matrix metalloproteinase-2 (MMP-2) gene variants and prostate cancer (PCa) risk in a Taiwanese population. MMP-2 genotypes did not influence individual PCa susceptibility.